120 German Hospitals entitled to negotiate fee for OncoSil
Filed with ASX · · 2 pages · English
Story so far
Earlier from OncoSil Medical
- OncoSil Medical Receives MDR Approval
- OncoSil receives $1.05m R&D tax incentive
- Oncosil completes $1 million Share Purchase Plan (SPP)
- Prospectus 2024 Share Purchase Plan (SPP) Offer
- OSL completes $7 M Placement and announces $1 M SPP
Later from OncoSil Medical
- Consolidation/Split - OSL
- OSL announces $8.7m capital raise to drive commercialisation
- Completion of Recruitment in PANCOSIL Study
- Completion of Recruitment in TRIPP-FFX Clinical Trial
- Appendix 4E and Annual Report
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical